Partner Fund Management »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Partner Fund Management

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Partner Fund Management from 13F filings

Historical chart of Partner Fund Management investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Partner Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Partner Fund Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.8M 7.8M 1.14
2024-06-30 $10M 7.8M 1.29

More positions owned by Partner Fund Management

Eli Lilly & Co. (LLY)
Tenet Healthcare Corp Com New (THC)
Cytokinetics Com New (CYTK)
Abbvie (ABBV)
Vertex Pharmaceuticals Incorporated (VRTX)
Intuitive Surgical Com New (ISRG)
Merck & Co (MRK)
Hca Holdings (HCA)
Universal Hlth Svcs CL B (UHS)
McKesson Corporation (MCK)
Argenx Se Sponsored Adr (ARGX)
UnitedHealth (UNH)
Acadia Healthcare (ACHC)
Axsome Therapeutics (AXSM)
Thermo Fisher Scientific (TMO)

View all positions for Partner Fund Management

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Ing Investment Management
Highbridge Capital Management
Calamos Advisors
Tenor Capital Management
Davidson Kempner Capital Management
Advent Capital Management
Steelhead Partners
Lazard Asset Management
BlackRock
Magnetar Financial
State Street Corporation
OZ Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Lord, Abbett & Co
Bnp Paribas Arbitrage, Snc

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1